[图书][B] Bayesian designs for phase I-II clinical trials
Y Yuan, HQ Nguyen, PF Thall - api.taylorfrancis.com
Bayesian Designs for Phase I–II Clinical Trials Page 1 Page 2 Ying Yuan The University of
Texas MD Anderson Cancer Center Houston, Texas, USA Hoang Q. Nguyen The University of …
Texas MD Anderson Cancer Center Houston, Texas, USA Hoang Q. Nguyen The University of …
[图书][B] Bayesian Designs for Phase I-II Clinical Trials
Y Yuan, HQ Nguyen, PF Thall - 2017 - books.google.com
Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …
[引用][C] Bayesian Designs for Phase I–II Clinical Trials
Y Yuan, HQ Nguyen, PF Thall - (No Title), 2017 - cir.nii.ac.jp
Bayesian Designs for Phase I-II Clinical Trials
Y Yuan, HQ Nguyen, PF Thall - 2017 - taylorfrancis.com
Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …
Bayesian designs for phase I–II clinical trials
Y Yuan, HQ Nguyen, PF Thall - 2017 - mdanderson.elsevierpure.com
Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …
[引用][C] Bayesian designs for phase I-II clinical trials
Y Yuan, HQ Nguyen, PF Thall - (No Title) - cir.nii.ac.jp
Bayesian designs for phase I-II clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
[图书][B] Bayesian Designs for Phase I-II Clinical Trials
Y Yuan, HQ Nguyen, PF Thall - 2017 - books.google.com
Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …
since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same …